V
VNDA
Vanda Pharmaceuticals Inc. Common Stock
$4.22
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Vanda Pharmaceuticals Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$4.63
P/E
—
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.70
Nov 4
Posts
No posts about VNDA yet.
About Vanda Pharmaceuticals Inc. Common Stock
Vanda Pharmaceuticals is a small US drug company. It develops and sells prescription medicines for mental health and sleep conditions, and it earns money from sales of those approved drugs. It also runs a pipeline of experimental drugs, which are medicines still being tested and not yet approved.